
<![CDATA[The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial ...
ABSTRACT Objectives: To evaluate the effects of the introduction of infliximab biosimilars on the cost of infliximab originator, the associated cost savings with infliximab biosimilars, and the market utilization of infliximab products in the first 5 years …